SCHEDULE 13G: Ayrton Capital and Affiliates Disclose 9.99% Stake in 60 Degrees Pharmaceuticals
Beneficial Ownership Report
Ayrton Capital LLC, Alto Opportunity Master Fund, SPC Segregated Master Portfolio B, and Waqas Khatri have jointly reported a 9.99% beneficial ownership stake in 60 Degrees Pharmaceuticals, Inc. through the holding of warrants.
Summary
- Ayrton Capital LLC, Alto Opportunity Master Fund, SPC Segregated Master Portfolio B, and Waqas Khatri (collectively, the "Reporting Persons") have filed a Schedule 13G, disclosing their beneficial ownership in 60 Degrees Pharmaceuticals, Inc.
- Each Reporting Person beneficially owns 163,480 shares of common stock, representing 9.99% of the issuer's class of securities.
- The reported shares are issuable upon the exercise of certain warrants held by the Reporting Persons.
- The shares issuable from the warrants are subject to a 9.99% beneficial ownership blocker, preventing ownership from exceeding this threshold.
- The percentage of class is calculated based on 1,472,891 shares of common stock outstanding as of March 27, 2025, as stated in the Issuer's Form 10-K, plus the 163,480 shares issuable from the warrants.
- Ayrton Capital LLC serves as the investment manager for Alto Opportunity Master Fund, SPC Segregated Master Portfolio B, and Waqas Khatri is the managing member of Ayrton Capital LLC and a director of Alto Opportunity Master Fund.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership, containing no positive or negative operational or financial news, thus maintaining a neutral sentiment.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership by an investment entity and its principals, common in the financial industry for transparency regarding significant stakes in publicly traded companies. It does not provide specific insights into the operational or strategic direction of 60 Degrees Pharmaceuticals, Inc. beyond the ownership structure.
Stakeholder Impact
- Shareholders: Disclosure of a significant, albeit passive, ownership stake by an investment fund and its principals provides transparency regarding the company's shareholder base. The existence of warrants, which can be exercised into common stock, indicates potential future dilution for existing shareholders, though this is a pre-existing condition of the warrants.
Key Dates
| Date | Description |
|---|---|
| 2025-03-27 | Date of Issuer's Form 10-K filing, which stated 1,472,891 shares of Common Stock outstanding. |
| 2025-03-31 | Date of event which requires the filing of this statement (beneficial ownership as of this date). |
| 2025-05-14 | Date of filing of this Schedule 13G statement. |
Keywords
60 Degrees Pharmaceuticals, Ayrton Capital, Alto Opportunity Master Fund, Waqas Khatri, Beneficial Ownership, Schedule 13G, Common Stock, Warrants, Investment Management, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.